{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:39:38Z","timestamp":1787960378498,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002015","name":"Chicago Baseball Cancer Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ihj.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T11:48:46Z","timestamp":1597060126000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction"],"prefix":"10.1016","volume":"72","author":[{"given":"Brian","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Singhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sadhanandham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2020.08.007_bib1","first-page":"339","article-title":"Iatrogenic drug-induced bronchospasm, cough, and bronchiolitis. Etiologic and physiopathologic aspects","volume":"13","author":"Cottin","year":"1996","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.ihj.2020.08.007_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chest.2017.10.016","article-title":"Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report","volume":"153","author":"Irwin","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.ihj.2020.08.007_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ihj.2020.08.007_bib4","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1016\/S1520-765X(03)90062-9","article-title":"Contribution of bradykinin to the cardioprotective effects of ACE inhibitors","volume":"5","author":"Murphey","year":"2003","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.ihj.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2020.08.007_bib6","first-page":"67","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"115","author":"Yusuf","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ihj.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting\u2013enzyme inhibition in stable coronary artery disease","volume":"351","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA internal medicine"},{"key":"10.1016\/j.ihj.2020.08.007_bib9","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jtcvs.2014.11.002","article-title":"2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines, a","volume":"149","author":"Fihn","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ihj.2020.08.007_bib11","first-page":"506","article-title":"Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ihj.2020.08.007_bib13","author":"NICE"},{"key":"10.1016\/j.ihj.2020.08.007_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.08.007_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1524-6175.2004.02866.x","article-title":"Angiotensin-converting enzyme inhibitors side effects? physiologic and non-physiologic considerations","volume":"6","author":"Sica","year":"2004","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ihj.2020.08.007_bib16","first-page":"PI21","article-title":"Factors that favor the occurrence of cough in patients treated with ramipril \u2013 a pharmacoepidemiological study","volume":"18","author":"Wyskida","year":"2012","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"key":"10.1016\/j.ihj.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03256570","article-title":"Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study","volume":"9","author":"Bahl","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ihj.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0028-3886.32785","article-title":"Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide","volume":"55","author":"Mv","year":"2007","journal-title":"Neurol India"},{"key":"10.1016\/j.ihj.2020.08.007_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijcard.2014.07.108","article-title":"The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease","volume":"176","author":"Brugts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2020.08.007_bib20","first-page":"421","article-title":"Efficacy and tolerability of trandolapril in mild to moderate hypertension - a double blind comparative clinical trial with enalapril in Indian population","volume":"50","author":"Shankar","year":"2006","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.ihj.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ihj.2014.10.419","article-title":"Blood pressure control and acceptability of Perindopril and its fixed dose combinations with Amlodipine or Indapamide, in younger patients with hypertension","volume":"66","author":"Bansal","year":"2014","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18087\/cardio.2018.9.10170","article-title":"Combined therapy of arterial hypertension with triple fixed-dose combination of amlodipine\/indapamide\/perindopril arginine in real clinical practice: the organization and the main results of the DOKAZATEL'STVO (Proof) study","volume":"58","author":"Kobalava","year":"2018","journal-title":"Kardiologiia"},{"key":"10.1016\/j.ihj.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40256-014-0067-2","article-title":"PIANIST Investigators: antihypertensive efficacy of triple combination perindopril\/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)","volume":"14","author":"T\u00f3th","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ihj.2020.08.007_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40261-014-0223-0","article-title":"Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR","volume":"34","author":"P\u00e1ll","year":"2014","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.ihj.2020.08.007_bib25","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s12325-017-0572-1","article-title":"The antihypertensive efficacy of the triple fixed combination of perindopril, indapamide, and amlodipine: the results of the PETRA study","volume":"34","author":"\u00c1brah\u00e1m","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.ihj.2020.08.007_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5152\/TurkThoracJ.2018.18014","article-title":"Angiotensin-converting enzyme inhibitors induce cough","volume":"20","author":"Y\u0131lmaz","year":"2019","journal-title":"Turkish thoracic journal"},{"key":"10.1016\/j.ihj.2020.08.007_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1378\/chest.95.3.544","article-title":"Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors","volume":"95","author":"Kaufman","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.ihj.2020.08.007_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bmj.296.6615.86","article-title":"Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors","volume":"296","author":"Bucknall","year":"1988","journal-title":"British medicaljournal (Clin Res Ed)."},{"key":"10.1016\/j.ihj.2020.08.007_bib29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1378\/chest.101.4.922","article-title":"Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma","volume":"101","author":"Kaufman","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ihj.2020.08.007_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.1995.tb04447.x","article-title":"Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study","volume":"39","author":"Wood","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2020.08.007_bib31","first-page":"76","article-title":"Captopril and bronchial reactivity","volume":"62","author":"Sala","year":"1986","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ihj.2020.08.007_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/FPC.0b013e328341041c","article-title":"Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough","volume":"21","author":"Grilo","year":"2011","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.ihj.2020.08.007_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/FPC.0b013e328348c6db","article-title":"Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes","volume":"21","author":"Mas","year":"2011","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.ihj.2020.08.007_bib34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/j.1552-4604.1994.tb01989.x","article-title":"Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure","volume":"34","author":"Ravid","year":"1994","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ihj.2020.08.007_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jclinepi.2006.06.017","article-title":"Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is","volume":"60","author":"Tumanan-Mendoza","year":"2007","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ihj.2020.08.007_bib36","first-page":"154","article-title":"Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril","volume":"125","author":"Dinicolantonio","year":"2013","journal-title":"PGM (Postgrad Med)"},{"key":"10.1016\/j.ihj.2020.08.007_bib37","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","article-title":"Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin\u2013angiotensin\u2013aldosterone system inhibitors involving 158 998 patients","volume":"33","author":"van Vark","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.08.007_bib38","first-page":"CD004136","article-title":"Antihypertensive agents for preventing diabetic kidney disease","volume":"12","author":"Lv","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ihj.2020.08.007_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ihj.2020.08.007_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2016.04.132","article-title":"ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure: a network meta-analysis","volume":"217","author":"Ricci","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2020.08.007_bib41","first-page":"1474","article-title":"Messerli, sripal Bangalore, chirag bavishi and stefano F. Rimoldi. Angiotensin-converting enzyme inhibitors in hypertension to use or not to use?","volume":"71","author":"Franz","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"33","key":"10.1016\/j.ihj.2020.08.007_bib42","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of Cardiology (ESC) and the European society of hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.ihj.2020.08.007_bib43","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology foundation\/American heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2020.08.007_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.08.007_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000159124","article-title":"The renin-angiotensin-system: approaches to guide angiotensin-converting-enzyme inhibition in patients with coronary artery disease","volume":"112","author":"Brugts","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.ihj.2020.08.007_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/HJH.0b013e328341d117","article-title":"A\u00a0pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals","volume":"29","author":"Brugts","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ihj.2020.08.007_bib47","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2020.08.007_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2020.08.007_bib49","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.08.007_bib50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0002-9149(92)90630-H","article-title":"Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril)","volume":"70","author":"Reisin","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2020.08.007_bib51","first-page":"333","article-title":"Complete spontaneous remission of cough induced by ACE inhibitors during chronic therapy in hypertensive patients","volume":"6","author":"Reisin","year":"1992","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ihj.2020.08.007_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10641963.2015.1026040","article-title":"A\u00a0prospective study of frequency and characteristics of cough during ACE inhibitor treatment","volume":"37","author":"Sato","year":"2015","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ihj.2020.08.007_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0011-393X(00)88520-3","article-title":"Effects of amlodipine, nifedipine GITS, and indomethacin on angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked, crossover study","volume":"60","author":"Fogari","year":"1999","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ihj.2020.08.007_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.33549\/physiolres.930605","article-title":"Enalapril and diltiazem co-administration and respiratory side effects of enalapril","volume":"54","author":"Fra\u0148ov\u00e1","year":"2005","journal-title":"Physiol Res"},{"key":"10.1016\/j.ihj.2020.08.007_bib55","first-page":"309","article-title":"The influence of inhaled furosemide on adverse effects of ACE-inhibitors in airways","volume":"102","author":"Franova","year":"2001","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.ihj.2020.08.007_bib56","doi-asserted-by":"crossref","first-page":"169S","DOI":"10.1378\/chest.129.1_suppl.169S","article-title":"Angiotensin-converting enzyme inhibitor-induced cough","volume":"129","author":"Dicpinigaitis","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ihj.2020.08.007_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3999\/jscpt.27.725","article-title":"Influence of type of questionnaire on the prevalence of coughing in patients taking angiotensin converting enzyme inhibitors (ACEI)","volume":"27","author":"Goto","year":"1996","journal-title":"Jpn J Clin Pharmacol Therapeut"},{"key":"10.1016\/j.ihj.2020.08.007_bib58","first-page":"157","article-title":"Cough and angioedema in patients receiving angiotensin-converting enzyme inhibitors. Are they always attributable to medication?","volume":"79","author":"Sebasti\u00e1n","year":"2011","journal-title":"Rev Argent Cardiol"},{"key":"10.1016\/j.ihj.2020.08.007_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0253-7613.62408","article-title":"Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: a prospective, randomized, open-label, comparative study","volume":"42","author":"Sangole","year":"2010","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ihj.2020.08.007_bib60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40261-019-00761-0","article-title":"Effectiveness and adherence to treatment with perindopril\/indapamide\/amlodipine single-pill combination in a Greek population with hypertension","volume":"39","author":"Tsioufis","year":"2019","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.ihj.2020.08.007_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40119-017-0085-7","article-title":"Single-pill combination of perindopril\/indapamide\/amlodipine in patients with uncontrolled hypertension: a randomized controlled trial","volume":"6","author":"Nedogoda","year":"2017","journal-title":"Cardiol therapy"},{"key":"10.1016\/j.ihj.2020.08.007_bib62","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/HJH.0000000000001359","article-title":"Blood pressure-lowering efficacy and safety of perindopril\/indapamide\/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial","volume":"35","author":"Mourad","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ihj.2020.08.007_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40268-018-0255-7","article-title":"Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II observational studies in mild to moderate hypertensive patients treated with perindopril and atorvastatin concomitantly","volume":"18","author":"Sampalis","year":"2018","journal-title":"Drugs R"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483220301917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483220301917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:23:33Z","timestamp":1762176213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483220301917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0019483220301917"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2020.08.007","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}